| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |